Urinalysis Market by Product (Dipsticks, Pregnancy & Fertility Kits, Reagents, Disposables, Automated, Semi-automated, POC Analyzers), Application (UTI, Diabetes, Kidney Diseases), End User (Hospitals, Labs, Home Care) & Test Type - Global Forecast to 2027

Abstract
The global urinalysis market is projected to reach USD 5.7 billion by 2027 from USD 3.9 billion in 2022, at a CAGR of 8.1% during the forecast period. Market growth is driven by factors such as increased production diagnostic products and government initiatives. On the other hand, challenges associated with urinalysis market like changing regulatory landscapes is the major factors hampering the growth of this market.

“The consumables segment accounted for the highest growth rate in the urinalysis market, by product, during the forecast period”

The urinalysis market is segmented into consumables and instruments. In 2021, consumables segment accounted for the highest growth rate in the urinalysis market. Increase in number of research & development and product approval and increased focus on reducing diseases like kidney and liver disease cases which are also associated with age increased age are major factor contributing to the growth of this segment.

“The pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market, by test type, during the forecast period”

The urinalysis market is segmented into pregnancy & fertility tests, biochemical tests and sediment urinalysis. In 2021, pregnancy & fertility tests segment accounted for the highest growth in the urinalysis market. Increasing funds for research, increasing awareness on fertility and pregnancy testing in women and increasing adoption of rapid pregnancy tests is major factor contributing to the growth of this segment.

“The disease screening segment accounted for the highest growth rate in the urinalysis market, by application, during the forecast period”

The urinalysis market is segmented into disease screening and pregnancy & fertility. In 2021, disease screening segment accounted for the highest growth rate in the urinalysis market. Increasing funding for the prevention of diseases like diabetes and Kidney diseases, growth in the number of diagnostic and imaging centers and improving healthcare infrastructure in emerging countries are major factor contributing to the growth of this segment.

“The diagnostic laboratories segment accounted for the highest growth in the urinalysis market, by end user, during the forecast period”

The urinalysis market is segmented into diagnostic laboratories, hospitals & clinics, home care settings and research laboratories and institutes based on end user. In 2021, the diagnostic laboratories segment accounted for the highest growth rate in the urinalysis market. Emerging markets offer lucrative growth opportunities, growing number of regulatory approvals for diagnostic technologies and rising incidence of life style related disorders are major factors contributing to the growth of this segment.

“Asia Pacific: The fastest-growing region in urinalysis market”

The global urinalysis market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Increasing number of conferences focused on creating awareness of diabetes and supportive government policies in the healthcare sector is driving the growth of the urinalysis market in this region.

The primary interviews conducted for this report can be categorized as follows:
•By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
•By Designation: C-level - 27%, D-level - 18%, and Others - 55%
•By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6% , and the Middle East & Africa – 4%

Lists of Companies Profiled in the Report:
•Siemens Healthineers AG (Germany)
•F. Hoffmann-La Roche Ltd. (Switzerland)
•Cardinal Health, Inc. (US)
•Abbott Laboratories (US)
•Danaher Corporation (US)
•Sysmex Corporation (Japan)
•Thermo Fisher Scientific, Inc. (US)
•Quidel Corporation (US)
•Becton, Dickinson and Company (US)
•Bio-Rad Laboratories, Inc. (US)
•EKF Diagnostics (UK)

Research Coverage:
This report provides a detailed picture of the global urinalysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product, test type, application, end user and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall urinalysis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities and challenges.

Content
Table of Contents

1INTRODUCTION31
1.1STUDY OBJECTIVES31
1.2MARKET DEFINITION31
1.2.1INCLUSIONS AND EXCLUSIONS32
1.3MARKETS COVERED32
1.3.1URINALYSIS MARKET SEGMENTATION32
1.3.2REGIONAL SCOPE33
1.3.3YEARS CONSIDERED33
1.4CURRENCY CONSIDERED34
1.5LIMITATIONS34
1.6STAKEHOLDERS34
1.7SUMMARY OF CHANGES35
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
2.2RESEARCH APPROACH36
FIGURE 1URINALYSIS MARKET: RESEARCH DESIGN36
2.2.1SECONDARY DATA37
2.2.1.1Key data from secondary sources37
2.2.1.2Activities involved in secondary research38
2.2.2PRIMARY DATA38
2.2.2.1Primary sources38
2.2.2.2Key data from primary sources39
2.2.2.3Key industry insights40
2.2.2.4Breakdown of primary interviews41
FIGURE 2BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS41
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION41
2.3MARKET SIZE ESTIMATION42
2.3.1BOTTOM-UP APPROACH42
2.3.1.1Approach 1: Company revenue estimation43
FIGURE 4BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH43
2.3.1.2Approach 2: Company presentations and primary interviews43
2.3.1.3CAGR projections44
FIGURE 5CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS44
2.3.2TOP-DOWN APPROACH44
FIGURE 6URINALYSIS MARKET: TOP-DOWN APPROACH44
2.4DATA TRIANGULATION45
FIGURE 7DATA TRIANGULATION METHODOLOGY45
2.5MARKET SHARE ANALYSIS46
2.6STUDY ASSUMPTIONS46
2.7GROWTH RATE ASSUMPTIONS46
2.8RISK ASSESSMENT47
2.8.1RISK ASSESSMENT: URINALYSIS MARKET47
2.9RECESSION IMPACT47
3EXECUTIVE SUMMARY49
FIGURE 8URINALYSIS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)49
FIGURE 9URINALYSIS MARKET, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)49
FIGURE 10URINALYSIS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)50
FIGURE 11URINALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)50
FIGURE 12URINALYSIS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION)51
4PREMIUM INSIGHTS52
4.1URINALYSIS MARKET OVERVIEW52
FIGURE 13RISING ADOPTION OF POC DIAGNOSTICS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD52
4.2URINALYSIS MARKET SHARE, BY PRODUCT, 2022 VS. 202752
FIGURE 14CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD52
4.3URINALYSIS MARKET SHARE, BY TEST TYPE, 2022 VS. 202753
FIGURE 15BIOCHEMICAL URINALYSIS TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD53
4.4URINALYSIS MARKET SHARE, BY APPLICATION, 2022 VS. 202753
FIGURE 16DISEASE SCREENING SEGMENT TO LEAD MARKET DURING FORECAST PERIOD53
4.5URINALYSIS MARKET SHARE, BY END USER, 2022 VS. 202754
FIGURE 17DIAGNOSTICS LABORATORIES TO ACCOUNT FOR DOMINANT MARKET SHARE DURING FORECAST PERIOD54
4.6URINALYSIS MARKET: REGIONAL GROWTH OPPORTUNITIES54
FIGURE 18ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD54
5MARKET OVERVIEW55
5.1INTRODUCTION55
5.2MARKET DYNAMICS55
FIGURE 19URINALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES55
5.2.1DRIVERS56
5.2.1.1Increasing burden of UTIs, diabetes, and liver & kidney diseases to impact market56
5.2.1.2Rising geriatric population and age-associated diseases to fuel market growth56
TABLE 1ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050)57
5.2.1.3Increasing adoption of POC urine diagnostic tests to drive market57
5.2.2RESTRAINTS58
5.2.2.1Availability of refurbished urine analyzers to pose challenges for market58
5.2.2.2High capital investments and lack of skilled laboratory technicians to restrain market growth58
5.2.3OPPORTUNITIES59
5.2.3.1Increasing investments in healthcare and life sciences to fuel growth in emerging markets59
5.2.3.2Technological advancements in urine analyzers to augment market growth59
5.2.3.3Increasing government initiatives and funding for preventive care to provide growth opportunities60
5.2.4CHALLENGES60
5.2.4.1Changing regulatory landscape to challenge market growth60
6URINALYSIS MARKET, BY PRODUCT61
6.1INTRODUCTION62
TABLE 2URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)62
6.2CONSUMABLES62
TABLE 3URINALYSIS MARKET FOR CONSUMABLES, BY TYPE, 2020–2027 (USD MILLION)62
TABLE 4URINALYSIS MARKET FOR CONSUMABLES, BY REGION, 2020–2027 (USD MILLION)63
6.2.1PREGNANCY & FERTILITY KITS63
6.2.1.1Rapid accessibility and testing convenience to drive market63
TABLE 5URINALYSIS MARKET FOR PREGNANCY & FERTILITY KITS, BY REGION, 2020–2027 (USD MILLION)64
6.2.2DIPSTICKS64
6.2.2.1Low cost and standard efficiency to increase use of dipsticks64
TABLE 6URINALYSIS MARKET FOR DIPSTICKS, BY REGION, 2020–2027 (USD MILLION)65
6.2.3DISPOSABLES65
6.2.3.1Urine collection cups to drive demand for disposables65
TABLE 7URINALYSIS MARKET FOR DISPOSABLES, BY REGION, 2020–2027 (USD MILLION)66
6.2.4REAGENTS66
6.2.4.1Increasing use of controls and calibrators to drive market growth66
TABLE 8URINALYSIS MARKET FOR REAGENTS, BY REGION, 2020–2027 (USD MILLION)67
6.3INSTRUMENTS67
TABLE 9KEY PRODUCTS IN INSTRUMENTS SEGMENT67
TABLE 10URINALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2020–2027 (USD MILLION)68
TABLE 11URINALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2020–2027 (USD MILLION)68
6.3.1AUTOMATED URINE ANALYZERS68
TABLE 12URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)69
TABLE 13URINALYSIS MARKET FOR AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)69
6.3.1.1Integrated urine analyzers69
6.3.1.1.1Higher workload in hospitals and laboratories to increase adoption of integrated urine analyzers69
TABLE 14URINALYSIS MARKET FOR INTEGRATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)70
6.3.1.2Sediment urine analyzers70
TABLE 15URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY TYPE, 2020–2027 (USD MILLION)70
TABLE 16URINALYSIS MARKET FOR SEDIMENT URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)71
6.3.1.2.1Microscopy analyzers71
6.3.1.2.1.1Increased adoption of automated microscopy urine analyzers to drive market growth71
TABLE 17URINALYSIS MARKET FOR MICROSCOPY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)71
6.3.1.2.2Flow cytometry analyzers72
6.3.1.2.2.1Accuracy and sensitivity of flow cytometry analyzers to drive adoption72
TABLE 18URINALYSIS MARKET FOR FLOW CYTOMETRY ANALYZERS, BY REGION, 2020–2027 (USD MILLION)72
6.3.1.3Biochemical urine analyzers72
6.3.1.3.1Increasing incidence of kidney diseases and UTIs to drive market72
TABLE 19URINALYSIS MARKET FOR BIOCHEMICAL URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)73
6.3.2SEMI-AUTOMATED URINE ANALYZERS73
6.3.2.1Extensive use of semi-automated urine analyzers in hospitals & clinics to drive segment growth73
TABLE 20URINALYSIS MARKET FOR SEMI-AUTOMATED URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)74
6.3.3POINT-OF-CARE URINE ANALYZERS74
6.3.3.1Need for rapid testing to drive demand for POC urine analyzers74
TABLE 21URINALYSIS MARKET FOR POC URINE ANALYZERS, BY REGION, 2020–2027 (USD MILLION)75
7URINALYSIS MARKET, BY TEST TYPE76
7.1INTRODUCTION77
TABLE 22URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)77
7.2PREGNANCY & FERTILITY TESTS77
7.2.1RISING DEMAND FOR RAPID SELF-CONTAINED TESTS TO DRIVE SEGMENT GROWTH77
TABLE 23URINALYSIS MARKET FOR PREGNANCY & FERTILITY TESTS, BY REGION, 2020–2027 (USD MILLION)78
7.3BIOCHEMICAL TESTS78
TABLE 24URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY TYPE, 2020–2027 (USD MILLION)79
TABLE 25URINALYSIS MARKET FOR BIOCHEMICAL TESTS, BY REGION, 2020–2027 (USD MILLION)79
7.3.1LABORATORY TESTS79
7.3.1.1Growing incidence of UTIs and other kidney diseases to drive market79
TABLE 26URINALYSIS MARKET FOR LABORATORY TESTS, BY REGION, 2020–2027 (USD MILLION)80
7.3.2POC TESTS80
7.3.2.1Convenience of POC testing to drive segment growth80
TABLE 27URINALYSIS MARKET FOR POC TESTS, BY REGION, 2020–2027 (USD MILLION)80
7.4SEDIMENT URINALYSIS81
7.4.1INCREASED ADOPTION OF AUTOMATED ANALYZERS TO DRIVE MARKET GROWTH81
TABLE 28URINALYSIS MARKET FOR SEDIMENT URINALYSIS, BY TYPE, 2020–2027 (USD MILLION)81
8URINALYSIS MARKET, BY APPLICATION82
8.1INTRODUCTION83
TABLE 29URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)83
8.2DISEASE SCREENING83
TABLE 30URINALYSIS MARKET FOR DISEASE SCREENING, BY TYPE, 2020–2027 (USD MILLION)84
TABLE 31URINALYSIS MARKET FOR DISEASE SCREENING, BY REGION, 2020–2027 (USD MILLION)84
8.2.1URINARY TRACT INFECTIONS84
8.2.1.1Increasing prevalence of UTIs to drive segment growth84
TABLE 32URINALYSIS MARKET FOR URINARY TRACT INFECTIONS, BY REGION, 2020–2027 (USD MILLION)85
8.2.2KIDNEY DISEASES85
8.2.2.1Rapidly growing geriatric population and prevalence of kidney diseases to fuel segment growth85
TABLE 33URINALYSIS MARKET FOR KIDNEY DISEASES, BY REGION, 2020–2027 (USD MILLION)86
8.2.3DIABETES86
8.2.3.1Development of advanced analytical tools for diabetes to drive market growth86
TABLE 34URINALYSIS MARKET FOR DIABETES, BY REGION, 2020–2027 (USD MILLION)86
8.2.4LIVER DISEASES87
8.2.4.1High prevalence of liver diseases to fuel segment growth87
TABLE 35URINALYSIS MARKET FOR LIVER DISEASES, BY REGION, 2020–2027 (USD MILLION)87
8.2.5OTHER DISEASE SCREENING APPLICATIONS87
TABLE 36URINALYSIS MARKET FOR OTHER DISEASE SCREENING APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)88
8.3PREGNANCY & FERTILITY88
8.3.1NEED FOR EARLY DETECTION OF PREGNANCY TO DRIVE SEGMENT88
TABLE 37URINALYSIS MARKET FOR PREGNANCY & FERTILITY, BY REGION, 2020–2027 (USD MILLION)89
9URINALYSIS MARKET, BY END USER90
9.1INTRODUCTION91
TABLE 38URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)91
9.2DIAGNOSTIC LABORATORIES91
9.2.1INCREASED OUTSOURCING OF DIAGNOSTIC TESTS BY HOSPITALS TO LABORATORIES TO AUGMENT MARKET91
TABLE 39URINALYSIS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)92
9.3HOSPITALS & CLINICS92
9.3.1INCREASING ADOPTION OF DIAGNOSTIC TOOLS FOR URINALYSIS TESTING TO DRIVE MARKET92
TABLE 40URINALYSIS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020–2027 (USD MILLION)93
9.4HOME CARE SETTINGS93
9.4.1INCREASING PREFERENCE FOR RAPID TESTING AND CONVENIENCE TO BOOST MARKET93
TABLE 41URINALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)94
9.5RESEARCH LABORATORIES & INSTITUTES94
9.5.1DEVELOPING INNOVATIVE TESTS FOR DISEASE DETECTION TO FUEL MARKET94
TABLE 42URINALYSIS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2020–2027 (USD MILLION)95
10URINALYSIS MARKET, BY REGION96
10.1INTRODUCTION97
TABLE 43URINALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)97
10.2NORTH AMERICA97
FIGURE 20NORTH AMERICA: URINALYSIS MARKET SNAPSHOT98
TABLE 44NORTH AMERICA: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)98
TABLE 45NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)99
TABLE 46NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)99
TABLE 47NORTH AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)99
TABLE 48NORTH AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)100
TABLE 49NORTH AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)100
TABLE 50NORTH AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)100
TABLE 51NORTH AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)101
TABLE 52NORTH AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)101
TABLE 53NORTH AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)101
TABLE 54NORTH AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)102
10.2.1RECESSION IMPACT102
10.2.2US102
10.2.2.1Rapid growth of geriatric population to drive market growth102
TABLE 55US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)103
TABLE 56US: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 57US: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)103
TABLE 58US: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 59US: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)104
TABLE 60US: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)104
TABLE 61US: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 62US: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)105
TABLE 63US: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)105
TABLE 64US: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)106
10.2.3CANADA106
10.2.3.1Increasing prevalence of chronic diseases to augment market106
TABLE 65CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)107
TABLE 66CANADA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 67CANADA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)107
TABLE 68CANADA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 69CANADA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)108
TABLE 70CANADA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)108
TABLE 71CANADA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)109
TABLE 72CANADA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)109
TABLE 73CANADA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)109
TABLE 74CANADA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)110
10.3EUROPE110
TABLE 75EUROPE: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)111
TABLE 76EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)111
TABLE 77EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)111
TABLE 78EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 79EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 80EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)112
TABLE 81EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)113
TABLE 82EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)113
TABLE 83EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)113
TABLE 84EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)114
TABLE 85EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)114
10.3.1RECESSION IMPACT114
10.3.2GERMANY115
10.3.2.1Increasing healthcare expenditure to fuel market growth115
TABLE 86GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)115
TABLE 87GERMANY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 88GERMANY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 89GERMANY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)116
TABLE 90GERMANY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 91GERMANY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)117
TABLE 92GERMANY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)117
TABLE 93GERMANY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)117
TABLE 94GERMANY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)118
TABLE 95GERMANY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)118
10.3.3UK118
10.3.3.1Rising government healthcare expenditure to propel market growth118
TABLE 96UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)119
TABLE 97UK: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 98UK: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)119
TABLE 99UK: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 100UK: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)120
TABLE 101UK: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)120
TABLE 102UK: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 103UK: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)121
TABLE 104UK: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)121
TABLE 105UK: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)122
10.3.4FRANCE122
10.3.4.1High R&D expenditure to provide growth opportunities122
TABLE 106FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)122
TABLE 107FRANCE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)123
TABLE 108FRANCE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)123
TABLE 109FRANCE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)123
TABLE 110FRANCE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 111FRANCE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)124
TABLE 112FRANCE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)124
TABLE 113FRANCE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)124
TABLE 114FRANCE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)125
TABLE 115FRANCE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)125
10.3.5ITALY125
10.3.5.1Large aging population to drive market growth125
TABLE 116ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)126
TABLE 117ITALY: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 118ITALY: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)126
TABLE 119ITALY: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 120ITALY: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)127
TABLE 121ITALY: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)127
TABLE 122ITALY: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 123ITALY: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)128
TABLE 124ITALY: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)128
TABLE 125ITALY: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)129
10.3.6SPAIN129
10.3.6.1Rising geriatric population to propel market129
TABLE 126SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)129
TABLE 127SPAIN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 128SPAIN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 129SPAIN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)130
TABLE 130SPAIN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 131SPAIN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)131
TABLE 132SPAIN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)131
TABLE 133SPAIN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)131
TABLE 134SPAIN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)132
TABLE 135SPAIN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)132
10.3.7REST OF EUROPE132
TABLE 136REST OF EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)133
TABLE 137REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)133
TABLE 138REST OF EUROPE: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)133
TABLE 139REST OF EUROPE: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 140REST OF EUROPE: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)134
TABLE 141REST OF EUROPE: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)134
TABLE 142REST OF EUROPE: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 143REST OF EUROPE: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)135
TABLE 144REST OF EUROPE: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)135
TABLE 145REST OF EUROPE: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)136
10.4ASIA PACIFIC136
FIGURE 21ASIA PACIFIC: URINALYSIS MARKET SNAPSHOT137
TABLE 146ASIA PACIFIC: URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)137
TABLE 147ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)138
TABLE 148ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 149ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)138
TABLE 150ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 151ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)139
TABLE 152ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)139
TABLE 153ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 154ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)140
TABLE 155ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)140
TABLE 156ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)141
10.4.1RECESSION IMPACT141
10.4.2CHINA141
10.4.2.1Improving healthcare infrastructure in China to support market growth141
TABLE 157CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)142
TABLE 158CHINA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)142
TABLE 159CHINA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 160CHINA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 161CHINA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)143
TABLE 162CHINA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)144
TABLE 163CHINA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)144
TABLE 164CHINA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)144
TABLE 165CHINA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)145
TABLE 166CHINA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)145
10.4.3JAPAN145
10.4.3.1Favorable regulatory framework to drive market growth145
TABLE 167JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)146
TABLE 168JAPAN: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 169JAPAN: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 170JAPAN: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)147
TABLE 171JAPAN: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 172JAPAN: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)148
TABLE 173JAPAN: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)148
TABLE 174JAPAN: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)148
TABLE 175JAPAN: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)149
TABLE 176JAPAN: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)149
10.4.4INDIA149
10.4.4.1Increasing investment in India’s healthcare system to drive market149
TABLE 177INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)150
TABLE 178INDIA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)150
TABLE 179INDIA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)150
TABLE 180INDIA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 181INDIA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)151
TABLE 182INDIA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)151
TABLE 183INDIA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 184INDIA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)152
TABLE 185INDIA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)152
TABLE 186INDIA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)153
10.4.5REST OF ASIA PACIFIC153
TABLE 187REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)153
TABLE 188REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)154
TABLE 189REST OF ASIA PACIFIC: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)154
TABLE 190REST OF ASIA PACIFIC: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)154
TABLE 191REST OF ASIA PACIFIC: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 192REST OF ASIA PACIFIC: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)155
TABLE 193REST OF ASIA PACIFIC: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)155
TABLE 194REST OF ASIA PACIFIC: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)156
TABLE 195REST OF ASIA PACIFIC: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)156
TABLE 196REST OF ASIA PACIFIC: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)156
10.5LATIN AMERICA157
TABLE 197LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)157
TABLE 198LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)158
TABLE 199LATIN AMERICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)158
TABLE 200LATIN AMERICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)158
TABLE 201LATIN AMERICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 202LATIN AMERICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)159
TABLE 203LATIN AMERICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)159
TABLE 204LATIN AMERICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)160
TABLE 205LATIN AMERICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)160
TABLE 206LATIN AMERICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)160
10.5.1RECESSION IMPACT161
10.6MIDDLE EAST & AFRICA161
TABLE 207MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)161
TABLE 208MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 209MIDDLE EAST & AFRICA: INSTRUMENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 210MIDDLE EAST & AFRICA: AUTOMATED URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)162
TABLE 211MIDDLE EAST & AFRICA: SEDIMENT URINE ANALYZERS MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 212MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)163
TABLE 213MIDDLE EAST & AFRICA: BIOCHEMICAL TESTS MARKET, BY TYPE, 2020–2027 (USD MILLION)163
TABLE 214MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)164
TABLE 215MIDDLE EAST & AFRICA: DISEASE SCREENING MARKET, BY TYPE, 2020–2027 (USD MILLION)164
TABLE 216MIDDLE EAST & AFRICA: URINALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)164
10.6.1RECESSION IMPACT165
11COMPETITIVE LANDSCAPE166
11.1OVERVIEW166
11.2STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN166
11.2.1OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS166
TABLE 217STRATEGIES DEPLOYED BY KEY COMPANIES166
11.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS168
FIGURE 22REVENUE SHARE ANALYSIS OF TOP PLAYERS168
11.4MARKET SHARE ANALYSIS169
11.4.1URINALYSIS MARKET169
FIGURE 23URINALYSIS MARKET SHARE, BY KEY PLAYER (2021)169
TABLE 218URINALYSIS MARKET: DEGREE OF COMPETITION169
11.5COMPANY EVALUATION QUADRANT170
11.5.1LIST OF EVALUATED VENDORS170
11.5.2STARS170
11.5.3EMERGING LEADERS170
11.5.4PERVASIVE PLAYERS171
11.5.5PARTICIPANTS171
FIGURE 24URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021171
11.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2021)172
11.6.1PROGRESSIVE COMPANIES172
11.6.2STARTING BLOCKS172
11.6.3RESPONSIVE COMPANIES172
11.6.4DYNAMIC COMPANIES172
FIGURE 25URINALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2021173
11.7COMPETITIVE BENCHMARKING174
11.7.1PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS174
FIGURE 26PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF LEADING PLAYERS174
TABLE 219URINALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS174
TABLE 220COMPANY PRODUCT FOOTPRINT174
TABLE 221COMPANY REGIONAL FOOTPRINT175
11.8COMPETITIVE SCENARIO175
11.8.1PRODUCT LAUNCHES AND APPROVALS175
TABLE 222KEY PRODUCT LAUNCHES AND REGULATORY APPROVALS175
11.8.2DEALS176
TABLE 223KEY DEALS176
12COMPANY PROFILES177
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
12.1KEY PLAYERS177
12.1.1SIEMENS HEALTHINEERS AG177
TABLE 224SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW177
FIGURE 27SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2021)178
12.1.2F. HOFFMANN-LA ROCHE LTD.180
TABLE 225F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW180
FIGURE 28F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2021)181
12.1.3CARDINAL HEALTH, INC.183
TABLE 226CARDINAL HEALTH, INC.: BUSINESS OVERVIEW183
FIGURE 29CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)184
12.1.4ABBOTT LABORATORIES186
TABLE 227ABBOTT LABORATORIES: BUSINESS OVERVIEW186
FIGURE 30ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021)187
12.1.5DANAHER CORPORATION189
TABLE 228DANAHER CORPORATION: BUSINESS OVERVIEW189
FIGURE 31DANAHER CORPORATION: COMPANY SNAPSHOT (2021)190
12.1.6SYSMEX CORPORATION192
TABLE 229SYSMEX CORPORATION: BUSINESS OVERVIEW192
FIGURE 32SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)192
12.1.7THERMO FISHER SCIENTIFIC, INC.194
TABLE 230THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW194
FIGURE 33THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021)195
12.1.8QUIDEL CORPORATION197
TABLE 231QUIDEL CORPORATION: BUSINESS OVERVIEW197
FIGURE 34QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)198
12.1.9BECTON, DICKINSON AND COMPANY200
TABLE 232BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW200
FIGURE 35BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)201
12.1.10BIO-RAD LABORATORIES, INC.202
TABLE 233BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW202
FIGURE 36BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)203
12.1.11EKF DIAGNOSTICS204
TABLE 234EKF DIAGNOSTICS: BUSINESS OVERVIEW204
FIGURE 37EKF DIAGNOSTICS: COMPANY SNAPSHOT (2021)205
12.2OTHER PLAYERS206
12.2.1ARKRAY, INC.206
TABLE 235ARKRAY, INC.: COMPANY OVERVIEW206
12.2.2ACON LABORATORIES, INC.207
TABLE 236ACON LABORATORIES, INC.: COMPANY OVERVIEW207
12.2.377 ELEKTRONIKA KFT.208
TABLE 23777 ELEKTRONIKA KFT.: COMPANY OVERVIEW208
12.2.4URIT MEDICAL ELECTRONIC GROUP CO., LTD.209
TABLE 238URIT MEDICAL ELECTRONIC GROUP CO., LTD.: COMPANY OVERVIEW209
12.2.5DIRUI INDUSTRIAL CO., LTD.210
TABLE 239DIRUI INDUSTRIAL CO., LTD.: COMPANY OVERVIEW210
12.2.6SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.211
TABLE 240SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW211
12.2.7BIOBASE GROUP212
TABLE 241BIOBASE GROUP: COMPANY OVERVIEW212
12.2.8ERBA MANNHEIM213
TABLE 242ERBA MANNHEIM: COMPANY OVERVIEW213
12.2.9ALPHATEC SCIENTIFIC213
TABLE 243ALPHATEC SCIENTIFIC: COMPANY OVERVIEW213
12.2.10TECO DIAGNOSTICS214
TABLE 244TECO DIAGNOSTICS: COMPANY OVERVIEW214
12.2.11ANALYTICON BIOTECHNOLOGIES AG215
TABLE 245ANALYTICON BIOTECHNOLOGIES AG: COMPANY OVERVIEW215
12.2.12BIOWAY BIOTECHNOLOGY216
TABLE 246BIOWAY BIOTECHNOLOGY: COMPANY OVERVIEW216
12.2.13HIGH TECHNOLOGY, INC.216
TABLE 247HIGH TECHNOLOGY, INC.: COMPANY OVERVIEW216
12.2.14AGAPPE DIAGNOSTICS217
TABLE 248AGAPPE DIAGNOSTICS: COMPANY OVERVIEW217
12.2.15GENRUI BIOTECH, INC.217
TABLE 249GENRUI BIOTECH, INC.: COMPANY OVERVIEW217
12.2.16SPINREACT S.A.218
TABLE 250SPINREACT S.A.: COMPANY OVERVIEW218
12.2.17DIALAB GMBH218
TABLE 251DIALAB GMBH: COMPANY OVERVIEW218
12.2.18QUANTIMETRIX CORPORATION219
TABLE 252QUANTIMETRIX CORPORATION: COMPANY OVERVIEW219
12.2.19BIOCARE CORPORATION220
TABLE 253BIOCARE CORPORATION: COMPANY OVERVIEW220
12.2.20RANDOX LABORATORIES LTD.220